Quantamental Technologies LLC Sells 817 Shares of Hill-Rom Holdings, Inc. (HRC)

Quantamental Technologies LLC reduced its stake in shares of Hill-Rom Holdings, Inc. (NYSE:HRC) by 26.4% during the first quarter, Holdings Channel reports. The institutional investor owned 2,278 shares of the medical technology company’s stock after selling 817 shares during the quarter. Quantamental Technologies LLC’s holdings in Hill-Rom were worth $241,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in the company. Securian Asset Management Inc grew its stake in shares of Hill-Rom by 1.2% during the fourth quarter. Securian Asset Management Inc now owns 8,231 shares of the medical technology company’s stock valued at $729,000 after buying an additional 100 shares during the last quarter. Mastrapasqua Asset Management Inc. grew its stake in shares of Hill-Rom by 0.7% during the fourth quarter. Mastrapasqua Asset Management Inc. now owns 14,830 shares of the medical technology company’s stock valued at $1,313,000 after buying an additional 105 shares during the last quarter. Johanson Financial Advisors Inc. grew its stake in shares of Hill-Rom by 4.8% during the fourth quarter. Johanson Financial Advisors Inc. now owns 2,437 shares of the medical technology company’s stock valued at $217,000 after buying an additional 111 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of Hill-Rom by 4.5% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 4,400 shares of the medical technology company’s stock worth $390,000 after purchasing an additional 189 shares during the last quarter. Finally, Metropolitan Life Insurance Co. NY grew its stake in shares of Hill-Rom by 1.3% in the fourth quarter. Metropolitan Life Insurance Co. NY now owns 21,482 shares of the medical technology company’s stock worth $1,902,000 after purchasing an additional 271 shares during the last quarter. 84.89% of the stock is currently owned by hedge funds and other institutional investors.

NYSE:HRC opened at $101.05 on Friday. The company has a quick ratio of 1.27, a current ratio of 1.69 and a debt-to-equity ratio of 1.10. Hill-Rom Holdings, Inc. has a 12 month low of $81.82 and a 12 month high of $108.68. The company has a market capitalization of $6.75 billion, a price-to-earnings ratio of 21.27, a P/E/G ratio of 1.75 and a beta of 0.91.

Hill-Rom (NYSE:HRC) last posted its earnings results on Friday, April 26th. The medical technology company reported $1.14 EPS for the quarter, topping analysts’ consensus estimates of $1.11 by $0.03. Hill-Rom had a net margin of 7.93% and a return on equity of 21.30%. The business had revenue of $714.20 million during the quarter, compared to the consensus estimate of $705.59 million. During the same quarter in the previous year, the firm posted $1.05 EPS. The firm’s revenue was up .5% on a year-over-year basis. On average, sell-side analysts forecast that Hill-Rom Holdings, Inc. will post 5.05 earnings per share for the current year.

Several research firms recently issued reports on HRC. Zacks Investment Research raised Hill-Rom from a “hold” rating to a “buy” rating and set a $118.00 target price on the stock in a research note on Tuesday, April 16th. ValuEngine cut Hill-Rom from a “buy” rating to a “hold” rating in a research note on Thursday, April 18th. Barclays raised their target price on Hill-Rom from $103.00 to $108.00 and gave the stock an “equal weight” rating in a research note on Monday, April 15th. Finally, Needham & Company LLC reissued a “buy” rating and issued a $116.00 target price on shares of Hill-Rom in a research note on Monday, March 11th. Four research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $109.88.

TRADEMARK VIOLATION NOTICE: This piece of content was published by Baseball Daily News and is owned by of Baseball Daily News. If you are reading this piece of content on another site, it was stolen and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.baseballdailydigest.com/news/2019/05/04/quantamental-technologies-llc-sells-817-shares-of-hill-rom-holdings-inc-hrc.html.

About Hill-Rom

Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.

See Also: Fiduciary

Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings, Inc. (NYSE:HRC).

Institutional Ownership by Quarter for Hill-Rom (NYSE:HRC)

Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.